![Torgny H. Svensson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Torgny H. Svensson
Corporate Officer/Principal at Karolinska Institutet
Torgny H. Svensson active positions
Companies | Position | Start | End |
---|---|---|---|
Karolinska Institutet | Corporate Officer/Principal | - | - |
Career history of Torgny H. Svensson
Former positions of Torgny H. Svensson
Companies | Position | Start | End |
---|---|---|---|
Independent Pharmaceutica AB
![]() Independent Pharmaceutica AB Medical DistributorsDistribution Services Independent Pharmaceutica AB is a privately owned company. The major owners are Karolinska Investment Fund, LH Advisory, Sandin &Co and The Foundation for Baltic and East European Studies (Östersjöstiftelsen). Independent Pharmaceutica aims to provide pharmacological solutions for treatment of nicotine addiction. The company is spun out of research from the Karolinska Institutet in Stockholm, Sweden. Tobacco use is the leading preventable cause of morbidity and premature death in the world.Currently over 1.2 billion people smoke worldwide and the number of annual deaths from tobacco-related diseases is over 4 million and rising. The costs for society are huge. With the new vaccine Niccine® against nicotine addiction, the health condition of millions of patients is expected to be improved. | Chief Tech/Sci/R&D Officer | 31/12/1996 | 24/11/2009 |
Founder | 24/11/2009 | 19/10/2011 | |
Corporate Officer/Principal | 24/11/2009 | 19/10/2011 |
Statistics
International
Sweden | 3 |
Operational
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoral
Distribution Services | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Independent Pharmaceutica AB
![]() Independent Pharmaceutica AB Medical DistributorsDistribution Services Independent Pharmaceutica AB is a privately owned company. The major owners are Karolinska Investment Fund, LH Advisory, Sandin &Co and The Foundation for Baltic and East European Studies (Östersjöstiftelsen). Independent Pharmaceutica aims to provide pharmacological solutions for treatment of nicotine addiction. The company is spun out of research from the Karolinska Institutet in Stockholm, Sweden. Tobacco use is the leading preventable cause of morbidity and premature death in the world.Currently over 1.2 billion people smoke worldwide and the number of annual deaths from tobacco-related diseases is over 4 million and rising. The costs for society are huge. With the new vaccine Niccine® against nicotine addiction, the health condition of millions of patients is expected to be improved. | Distribution Services |
- Stock Market
- Insiders
- Torgny H. Svensson
- Experience